Physical performance in long-term survivors of acute leukaemia in childhood

Eur J Pediatr. 1998 Jun;157(6):464-7. doi: 10.1007/s004310050854.

Abstract

The aim of this study was to assess the physical performance in long-term survivors of acute leukaemia in childhood and to evaluate the effects of anthracycline therapy. Electrocardiography, echocardiography and spiroergometry were carried out on 56 patients aged 9-28 years, of whom 44 patients had been treated with 15-483 mg/m2 doxorubicin (or equivalent). Acute leukaemia had been diagnosed 1.5-16 years earlier. Of the patients 75% reached normal maximal oxygen uptake, 69% normal oxygen uptake at the anaerobic threshold and 95% normal maximal work rate. Of the patients 75% achieved adequate values for maximal heart rate and 78% normal blood lactate concentration. No difference was seen between patients treated with and without anthracyclines.

Conclusion: The results of this study provide little evidence for cardiopulmonary impairment in long-term survivors of ALL. Both the cardiac function, as evaluated by ECG and echocardiography, and the physical performance in spiroergometry are normal in a large number of these patients. Anthracycline treatment does not appear to have a negative effect on these parameters.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / adverse effects*
  • Child
  • Child, Preschool
  • Daunorubicin / administration & dosage
  • Daunorubicin / adverse effects*
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects*
  • Echocardiography
  • Electrocardiography
  • Female
  • Heart Rate
  • Humans
  • Infant
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / physiopathology*
  • Male
  • Oxygen Consumption
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / physiopathology*
  • Quality of Life
  • Spirometry
  • Time Factors

Substances

  • Antibiotics, Antineoplastic
  • Doxorubicin
  • Daunorubicin